NCT05004285 - Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis | Biotech Hunter

Enrollment

398

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

High Risk Prostate Carcinoma

Interventions

DRUG

[F-18]Florastamin

A single dose of \[F-18\]Florastamin at 10 ± 1 mCi is IV administered at Visit 2, and \[F-18\]Florastamin PET/CT images are obtained from the head to thigh after 110 ± 10 minutes.

Trial Locations (5)

Unknown

National Cancer Center, Gyeonggi-do

The Catholic University of Korea, St. Vincent's Hospital, Gyeonggi-do

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul